Physician profile
Richard Taylor
NPI 1033154158
$1,157.97
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $451 · 2021: $33.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.23 | 2019-2021 | |
| Amgen INC. | $198.78 | 2019-2020 | |
| Therapeuticsmd, INC. | $107.60 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.02 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $71.64 | 2019 | |
| Astellas Pharma US INC | $69.78 | 2019-2020 | |
| Pfizer INC. | $46.23 | 2019-2020 | |
| Hologic Sales and Service, LLC | $44.43 | 2019-2020 | |
| Daiichi Sankyo INC. | $32.45 | 2019 | |
| Ethicon US, LLC | $31.99 | 2020 | |
| Mylan Pharmaceuticals INC. | $28.00 | 2020 | |
| Merck Sharp & Dohme LLC | $26.53 | 2019-2020 | |
| Boston Scientific Corporation | $19.25 | 2019 | |
| Roche Diagnostics Corporation | $19.00 | 2019 | |
| Avanos Medical | $15.74 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $15.67 | 2021 | |
| Covidien LP | $15.21 | 2019 | |
| Coopersurgical, INC. | $14.58 | 2020 | |
| Dysis Medical, INC. | $13.15 | 2020 | |
| Allergan, INC. | $12.82 | 2019 | |
| Mission Pharmacal Company | $11.87 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.